Literature DB >> 27639006

Diagnosis and treatment of effort-induced thrombosis of the axillary subclavian vein due to venous thoracic outlet syndrome.

Chandu Vemuri1, Payam Salehi2, Jaime Benarroch-Gampel3, Lauren N McLaughlin3, Robert W Thompson4.   

Abstract

Venous thoracic outlet syndrome (VTOS) is uncommon but most frequently occurs in young, active, healthy patients. This condition typically presents as subclavian vein (SCV) effort thrombosis, also known as Paget-Schroetter syndrome. The pathophysiology underlying VTOS is chronic repetitive compression injury of the SCV in the costoclavicular space, resulting in progressive venous scarring, focal stenosis, and eventual thrombosis. Clinical evaluation includes a history and physical examination followed by catheter-based venography, for definitive confirmation of the diagnosis and initial treatment with pharmacomechanical thrombolysis. After restoration of SCV patency, patients are maintained with anticoagulation and surgical therapy is usually planned within 4 to 6 weeks. Surgical management of VTOS can be accomplished via different protocols involving either the transaxillary, infraclavicular or paraclavicular approaches to thoracic outlet decompression. The paraclavicular approach is emphasized in this review, because it affords the surgeon the ability to safely perform complete thoracic outlet decompression (complete anterior and middle scalenectomy, removal of the entire first rib, and resection of the subclavius muscle and costoclavicular ligament), along with definitive management of the damaged SCV (external venolysis, intraoperative venography, and direct vein reconstruction, if needed, using patch angioplasty or bypass grafting), in one operative setting. After surgical therapy, interval anticoagulation and a comprehensive physical therapy and rehabilitation program are important in achieving a return to full function. Current protocols on the basis of the paraclavicular surgical approach have thereby routinely provided patients with lasting symptomatic relief, freedom from indefinite anticoagulation, and the ability to return to unrestricted upper extremity activity.
Copyright © 2016 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27639006     DOI: 10.1016/j.jvsv.2016.01.004

Source DB:  PubMed          Journal:  J Vasc Surg Venous Lymphat Disord


  6 in total

1.  Rivaroxaban-Induced Hypersensitivity Syndrome.

Authors:  Charles-Olivier Chiasson; Arnaud Canneva; François-Olivier Roy; Maxime Doré
Journal:  Can J Hosp Pharm       Date:  2017-08-31

2.  Treatment-Related Outcomes in Paget-Schroetter Syndrome-A Cross-Sectional Investigation.

Authors:  Riten Kumar; Katherine Harsh; Surbhi Saini; Sarah H O'Brien; Joseph Stanek; Patrick Warren; Jean Giver; Michael R Go; Bryce A Kerlin
Journal:  J Pediatr       Date:  2018-12-07       Impact factor: 4.406

3.  Effort Thrombosis in 2 Athletes Suspected of Musculoskeletal Injury.

Authors:  Ross Mattox; Robert J Trager; Norman W Kettner
Journal:  J Chiropr Med       Date:  2020-08-21

4.  A Patient-Centered Approach to Guide Follow-Up and Adjunctive Testing and Treatment after First Rib Resection for Venous Thoracic Outlet Syndrome Is Safe and Effective.

Authors:  Colin P Ryan; Nicolas J Mouawad; Patrick S Vaccaro; Michael R Go
Journal:  Diagnostics (Basel)       Date:  2018-01-23

5.  Thoracic Outlet Syndrome in Major League Baseball Pitchers: Return to Sport and Performance Metrics After Rib Resection.

Authors:  Michael T Arnold; Christopher M Hart; Danielle E Greig; Rishi Trikha; Hugh A Gelabert; Kristofer J Jones
Journal:  Orthop J Sports Med       Date:  2022-04-21

6.  Spontaneous bilateral subclavian vein thrombosis in a 40-year-old man: A case report.

Authors:  Chun-Yen Huang; Yen-Hung Wu; I-Jeng Yeh; Yun-Yi Chen; Fung-Ya Kung
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.